Bausch Health Companies Inc (BHC : TSX)
Common Stock
Follow BHC
BHC
Bausch Health Companies Inc
Performance
1 Day
+1.18%
1 Week
+1.43%
1 Month
+35.09%
YTD
+21.47%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$4.46B
52W High
$12.65
52W Low
$6.10
P/E Ratio
-
50 Day MA
$9.11
200 Day MA
$7.99
Beta
0.28
Dividend Yield
-
WA Score
How BHC stacks up against 944 Canadian stocks
out of 99
- Value9
Not profitable over the last 12 months.
- Quality
- Momentum84
21.5% this year, above its 200-day average, 91% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
BHC returns since 2016
Bausch Health Companies Inc has returned −6.7% a year over the last 10 years, with 5 up years out of 9 full calendar years. Its deepest fall was −96.2% (Jan 2016 to Jul 2022).
1 year / yr
+39.8%
3 years / yr
+10.0%
5 years / yr
−18.4%
10 years / yr
−6.7%
Calendar-year returns
- 2016*−85.8%
- 2017+34.6%
- 2018−3.6%
- 2019+53.9%
- 2020−32.1%
- 2021+32.3%
- 2022−75.7%
- 2023+25.1%
- 2024+9.3%
- 2025−18.0%
- 2026*+26.4%
* Partial year (first year of data, or year to date).
$10,000 invested in BHC
- 1 year ago$13,979
- 5 years ago$3,611
- 10 years ago$5,015
- Best year
- 2019: +53.9%
- Worst year
- 2022: −75.7%
- All-time high in our data
- $144 on Jan 6, 2016 · now −91.6%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jan 2016 to Nov 2026. Past returns do not predict future ones.
Earnings
BHC earnings history
Bausch Health Companies Inc beat the EPS estimate in 3 of its last 4 reported quarters.
Next report
Feb 17, 2027 · after close
EPS estimate $1.32
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 30, 2026 | Oct 28, 2026 | $1.77 | $1.24 | +42.7% |
| Jun 30, 2026 | Jul 29, 2026 | $1.26 | $1.01 | +24.8% |
| Mar 31, 2026 | Apr 29, 2026 | $0.78 | $0.69 | +13.0% |
| Dec 31, 2025 | Feb 18, 2026 | $1.10 | $1.21 | −9.1% |
| Sep 30, 2025 | Oct 29, 2025 | $1.16 | $1.06 | +9.4% |
| Jun 30, 2025 | Jul 30, 2025 | $0.91 | $0.94 | −3.2% |
| Mar 31, 2025 | Apr 30, 2025 | $0.61 | $0.85 | −28.2% |
| Dec 31, 2024 | Feb 20, 2025 | $1.16 | $1.13 | +2.9% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past BHC? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Bausch Health Companies Inc insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$815 | 100 | CA$8.15 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$809 | 100 | CA$8.09 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$145,070 | 17,800 | CA$8.15 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$5,719 | 700 | CA$8.17 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$10,634 | 1,300 | CA$8.18 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$1,638 | 200 | CA$8.19 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$38,540 | 4,700 | CA$8.20 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$203,750 | 25,000 | CA$8.15 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$2,463 | 300 | CA$8.21 |
| Nov 26, 08 | Sell | Melnyk, Eugene Individual · CA$196,697 | 23,900 | CA$8.23 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $12.02 | $12.26 | $11.97 | $12.05 | $12.05 | 901,674 |
| 11/13/2026 | $11.76 | $11.99 | $11.67 | $11.91 | $11.91 | 484,273 |
| 11/12/2026 | $11.96 | $12.02 | $11.76 | $11.76 | $11.76 | 329,236 |
| 11/11/2026 | $11.88 | $12.04 | $11.56 | $11.91 | $11.91 | 523,698 |
| 11/10/2026 | $11.82 | $11.85 | $11.57 | $11.78 | $11.78 | 662,127 |
| 11/9/2026 | $11.62 | $12.10 | $11.59 | $11.88 | $11.88 | 620,695 |
| 11/6/2026 | $11.15 | $11.58 | $11.15 | $11.56 | $11.56 | 850,864 |
| 11/5/2026 | $11.60 | $11.71 | $11.16 | $11.19 | $11.19 | 898,272 |
| 11/4/2026 | $11.56 | $11.81 | $11.50 | $11.67 | $11.67 | 522,306 |
| 11/3/2026 | $11.09 | $11.45 | $11.07 | $11.41 | $11.41 | 640,076 |
Analyst Price Targets
Based on analyst covering BHC · as of Sep 17, 2026
Wall Street analysts forecast BHC stock price to fall 41.8% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-41.8% Upside
Current Price
C$12.05
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
85.6%
Annualized
90-Day Vol
77.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$14.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$12.79 | C$9.52 – C$17.18 |
| 60 trading days | C$13.57 | C$8.94 – C$20.61 |
| 90 trading days | C$14.41 | C$8.64 – C$24.02 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Financials
- Revenue (TTM)
- $11.11B
- EBITDA
- $4.17B
- Profit Margin
- -7.57%
- ROE (TTM)
- -11040.00%
- EPS (Diluted)
- -3.14
- Book Value
- -4.98
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About BHC
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Free with a Wealth Awesome account
Keep analysing BHC, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
